Broncus Holding Corp

02216

Company Profile

  • Business description

    Broncus Holding Corp is a medical device company focused on the development of interventional pulmonology products. It is engaged in the field of interventional pulmonology, providing lung solutions in China and globally. The integrated interventional pulmonology platform addresses the pain points of the existing diagnosis and treatment paradigms and unmet medical needs for lung diseases by improving the diagnosis and treatment effects of lung cancer and COPD. The company offers products like Archimedes System, LungPoint, BioStar, FleXNeedle Biopsy Needle, RF-II, and InterVapor System among others. Geographically, the company derives a majority of its revenue from the Chinese Mainland, and the rest from European Union, USA, and other regions.

  • Contact

    No. 88 Jiangling Road, Xixing Street
    Room 801, 8th Floor, Building 8
    Binjiang District
    Hangzhou
    CHN

    T: +86 57186595016

    https://www.broncus.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    208

Stocks News & Analysis

stocks

2 undervalued ASX shares report

These two ASX shares are trading at a discount to our fair value. 
stocks

Turmoil at WiseTech

Board members step down over differences on the role of former CEO Richard White.
video

What does the RBA rate cut mean for investors?

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,498.0062.10-0.73%
CAC 408,090.9963.52-0.78%
DAX 4022,425.93138.370.62%
Dow JONES (US)43,461.2133.190.08%
FTSE 1008,658.980.39-0.00%
HKSE23,227.63113.98-0.49%
NASDAQ19,286.93237.08-1.21%
Nikkei 22538,281.45495.49-1.28%
NZX 50 Index12,307.27224.45-1.79%
S&P 5005,983.2529.88-0.50%
S&P/ASX 2008,251.9056.30-0.68%
SSE Composite Index3,367.255.77-0.17%

Market Movers